Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/ee/36/b7/ee36b702-2a97-c047-0f32-c339c6acc027/mza_11381342764586184688.jpg/600x600bb.jpg

Perspectives by the Leerink Center for Pharmacoeconomics

The Leerink Center for Pharmacoeconomics

11 episodes

6 days ago

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, to discuss the impact of the Inflation Reduction...

Investing

Business

RSS

All content for Perspectives by the Leerink Center for Pharmacoeconomics is the property of The Leerink Center for Pharmacoeconomics and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Business

https://storage.googleapis.com/com-resonaterecordings-public/cover-art/irphOWOF2qKuawtJ8ysQfiRfKz9SByJhaZ1Y82dJ.png

Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA

Perspectives by the Leerink Center for Pharmacoeconomics

2 months ago

Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA